Literature DB >> 29125980

Molecular insights into cortico-striatal miscommunications in Huntington's disease.

Matthew B Veldman1, X William Yang2.   

Abstract

Huntington's disease (HD), a dominantly inherited neurodegenerative disease, is defined by its genetic cause, a CAG-repeat expansion in the HTT gene, its motor and psychiatric symptomology and primary loss of striatal medium spiny neurons (MSNs). However, the molecular mechanisms from genetic lesion to disease phenotype remain largely unclear. Mouse models of HD have been created that exhibit phenotypes partially recapitulating those in the patient, and specifically, cortico-striatal disconnectivity appears to be a shared pathogenic event shared by HD mouse models and patients. Molecular studies have begun to unveil converging molecular and cellular pathogenic mechanisms that may account for cortico-striatal miscommunication in various HD mouse models. Systems biological approaches help to illuminate synaptic molecular networks as a nexus for HD cortio-striatal pathogenesis, and may offer new candidate targets to modify the disease.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29125980      PMCID: PMC5825262          DOI: 10.1016/j.conb.2017.10.019

Source DB:  PubMed          Journal:  Curr Opin Neurobiol        ISSN: 0959-4388            Impact factor:   6.627


  69 in total

1.  New coumarins from the roots of Angelica dahurica var. formosana cv. Chuanbaizhi and their inhibition on NO production in LPS-activated RAW264.7 cells.

Authors:  Gai-Gai Deng; Wei Wei; Xiu-Wei Yang; You-Bo Zhang; Wei Xu; Ning-Bo Gong; Yang Lü; Feng-Feng Wang
Journal:  Fitoterapia       Date:  2015-01-31       Impact factor: 2.882

2.  Genetic rescue of CB1 receptors on medium spiny neurons prevents loss of excitatory striatal synapses but not motor impairment in HD mice.

Authors:  Alipi V Naydenov; Marja D Sepers; Katie Swinney; Lynn A Raymond; Richard D Palmiter; Nephi Stella
Journal:  Neurobiol Dis       Date:  2014-08-15       Impact factor: 5.996

3.  Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release.

Authors:  He Li; Travis Wyman; Zhao-Xue Yu; Shi-Hua Li; Xiao-Jiang Li
Journal:  Hum Mol Genet       Date:  2003-08-15       Impact factor: 6.150

4.  Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor.

Authors:  Zachary C Baquet; Jessica A Gorski; Kevin R Jones
Journal:  J Neurosci       Date:  2004-04-28       Impact factor: 6.167

5.  Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse.

Authors:  B R Miller; J L Dorner; M Shou; Y Sari; S J Barton; D R Sengelaub; R T Kennedy; G V Rebec
Journal:  Neuroscience       Date:  2008-02-15       Impact factor: 3.590

6.  Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington's disease mice.

Authors:  Y P Deng; T Wong; C Bricker-Anthony; B Deng; A Reiner
Journal:  Neurobiol Dis       Date:  2013-08-19       Impact factor: 5.996

7.  Mutant Huntingtin alters retrograde transport of TrkB receptors in striatal dendrites.

Authors:  Géraldine Liot; Diana Zala; Patrick Pla; Guillaume Mottet; Matthieu Piel; Frédéric Saudou
Journal:  J Neurosci       Date:  2013-04-10       Impact factor: 6.167

8.  Genetically-directed Sparse Neuronal Labeling in BAC Transgenic Mice through Mononucleotide Repeat Frameshift.

Authors:  Xiao-Hong Lu; X William Yang
Journal:  Sci Rep       Date:  2017-03-08       Impact factor: 4.379

9.  Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease.

Authors:  Xiaofeng Gu; Véronique M André; Carlos Cepeda; Shi-Hua Li; Xiao-Jiang Li; Michael S Levine; X William Yang
Journal:  Mol Neurodegener       Date:  2007-04-30       Impact factor: 14.195

10.  Synaptic mutant huntingtin inhibits synapsin-1 phosphorylation and causes neurological symptoms.

Authors:  Qiaoqiao Xu; Shanshan Huang; Mingke Song; Chuan-En Wang; Sen Yan; Xudong Liu; Marta A Gaertig; Shan Ping Yu; He Li; Shihua Li; Xiao-Jiang Li
Journal:  J Cell Biol       Date:  2013-09-30       Impact factor: 10.539

View more
  14 in total

1.  Motivational Impairment is Accompanied by Corticoaccumbal Dysfunction in the BACHD-Tg5 Rat Model of Huntington's Disease.

Authors:  Natalie E Zlebnik; Iness Gildish; Thibaut Sesia; Aurelie Fitoussi; Ellen A Cole; Brian P Carson; Roger Cachope; Joseph F Cheer
Journal:  Cereb Cortex       Date:  2019-12-17       Impact factor: 5.357

2.  RNAi-Based GluN3A Silencing Prevents and Reverses Disease Phenotypes Induced by Mutant huntingtin.

Authors:  Sonia Marco; Alvaro Murillo; Isabel Pérez-Otaño
Journal:  Mol Ther       Date:  2018-06-15       Impact factor: 11.454

3.  Synaptic Dysfunction in Huntington's Disease: Lessons from Genetic Animal Models.

Authors:  Carlos Cepeda; Michael S Levine
Journal:  Neuroscientist       Date:  2020-11-16       Impact factor: 7.235

4.  Dynamics of huntingtin protein interactions in the striatum identifies candidate modifiers of Huntington disease.

Authors:  Todd M Greco; Christopher Secker; Eduardo Silva Ramos; Joel D Federspiel; Jeh-Ping Liu; Alma M Perez; Ismael Al-Ramahi; Jeffrey P Cantle; Jeffrey B Carroll; Juan Botas; Scott O Zeitlin; Erich E Wanker; Ileana M Cristea
Journal:  Cell Syst       Date:  2022-02-10       Impact factor: 11.091

5.  Striatal Direct and Indirect Pathway Output Structures Are Differentially Altered in Mouse Models of Huntington's Disease.

Authors:  Joshua Barry; Garnik Akopian; Carlos Cepeda; Michael S Levine
Journal:  J Neurosci       Date:  2018-04-24       Impact factor: 6.167

6.  Uninterrupted CAG repeat drives striatum-selective transcriptionopathy and nuclear pathogenesis in human Huntingtin BAC mice.

Authors:  Xiaofeng Gu; Jeffrey Richman; Peter Langfelder; Nan Wang; Shasha Zhang; Monica Bañez-Coronel; Huei-Bin Wang; Lucia Yang; Lalini Ramanathan; Linna Deng; Chang Sin Park; Christopher R Choi; Jeffrey P Cantle; Fuying Gao; Michelle Gray; Giovanni Coppola; Gillian P Bates; Laura P W Ranum; Steve Horvath; Christopher S Colwell; X William Yang
Journal:  Neuron       Date:  2022-02-02       Impact factor: 18.688

7.  Cortical circuit alterations precede motor impairments in Huntington's disease mice.

Authors:  Johanna Burgold; Elena Katharina Schulz-Trieglaff; Kerstin Voelkl; Sara Gutiérrez-Ángel; Jakob Maximilian Bader; Fabian Hosp; Matthias Mann; Thomas Arzberger; Rüdiger Klein; Sabine Liebscher; Irina Dudanova
Journal:  Sci Rep       Date:  2019-04-29       Impact factor: 4.379

8.  Genetic cooperativity in multi-layer networks implicates cell survival and senescence in the striatum of Huntington's disease mice synchronous to symptoms.

Authors:  Erwan Bigan; Satish Sasidharan Nair; François-Xavier Lejeune; Hélissande Fragnaud; Frédéric Parmentier; Lucile Mégret; Marc Verny; Jeff Aaronson; Jim Rosinski; Christian Neri
Journal:  Bioinformatics       Date:  2020-01-01       Impact factor: 6.937

9.  M2 cortex-dorsolateral striatum stimulation reverses motor symptoms and synaptic deficits in Huntington's disease.

Authors:  Sara Fernández-García; Sara Conde-Berriozabal; Esther García-García; Clara Gort-Paniello; David Bernal-Casas; Gerardo García-Díaz Barriga; Javier López-Gil; Emma Muñoz-Moreno; Guadalupe Soria; Leticia Campa; Francesc Artigas; Manuel José Rodríguez; Jordi Alberch; Mercè Masana
Journal:  Elife       Date:  2020-10-05       Impact factor: 8.140

10.  Early impairment of thalamocortical circuit activity and coherence in a mouse model of Huntington's disease.

Authors:  Justin L Shobe; Elissa J Donzis; Kwang Lee; Samiksha Chopra; Sotiris C Masmanidis; Carlos Cepeda; Michael S Levine
Journal:  Neurobiol Dis       Date:  2021-07-16       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.